This protocol is judged by an institutional review board, an impartial group that critiques any clinical trials involving people. If a analyze entails a Schedule I drug, when the board approves the protocol as ethical, the scientists really have to make an application for an investigational new drug (IND) quantity through the FDA.Some scientists a